In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Creating, launching and funding Life Sciences ventures is a difficult and daunting task, especially given recent market conditions. This course is a practical, hands-on field course primarily designed ...

In recent years, generative AI (GenAI) has become a prominent topic of discussion in life sciences. However, I often hear from my life science clients about the need for more clarity around its actual ...

Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost. Delayed clinical trials, regulatory approvals, and ...